Sansure Biotech Inc. (SHA:688289)
China flag China · Delayed Price · Currency is CNY
14.76
-0.25 (-1.67%)
Nov 17, 2026, 3:00 PM CST

Sansure Biotech Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,6243,9684,5904,2333,2132,636
Trading Asset Securities
-157.1139.67548.282,4512,046
Cash & Short-Term Investments
3,6244,1254,7304,7825,6644,683
Cash Growth
-9.52%-12.78%-1.09%-15.57%20.95%11.70%
Accounts Receivable
691.18629.62560.69692.261,298807.66
Other Receivables
23.6628.3627.5823.4982.4114.3
Receivables
714.84657.98588.27715.751,381821.95
Inventory
491.36413.69392.75376.63355.31369.5
Other Current Assets
93.1577.1578.775.45125.8392.09
Total Current Assets
4,9235,2745,7905,9507,5255,966
Property, Plant & Equipment
1,2781,3351,1131,043785.27481.03
Long-Term Investments
1,6491,3151,096974.33657.43513.23
Goodwill
849.33798.397.667.66--
Other Intangible Assets
547497.4334.67283.2879.1245.55
Long-Term Deferred Tax Assets
102.8785.8369.2873.8269.6225
Long-Term Deferred Charges
174.37175.37147.2797.0546.716.26
Other Long-Term Assets
69.8945.6847.0425.1610.1943.08
Total Assets
9,5949,5278,6048,4549,1747,090

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
350.95192.33225.78271.14586.26188.82
Accrued Expenses
76.04260.03290.03363.33622.39231.82
Short-Term Debt
119.4593.5199--
Current Portion of Leases
90.255.345.2811.114.268.49
Current Income Taxes Payable
21.582.590.2117.66145.2580.16
Current Unearned Revenue
35.8846.8864.5532.8153.1178.64
Other Current Liabilities
389.76555.33159.94214.12150.4576.01
Total Current Liabilities
1,0841,206754.8919.151,572663.93
Long-Term Debt
1,290966.3396.65---
Long-Term Leases
5.6712.1711.9218.2113.66.41
Long-Term Unearned Revenue
56.7262.9439.8832.4930.5325.68
Long-Term Deferred Tax Liabilities
96.3489.1654.7559.4519.0413.01
Other Long-Term Liabilities
----26.09-
Total Liabilities
2,5332,3371,2581,0291,661709.03

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
574.94579.39582.39588.46588.46400
Additional Paid-In Capital
1,4731,5651,7021,9081,9142,065
Retained Earnings
5,0395,0855,1945,1775,3714,082
Treasury Stock
-145.81-143.23-274.29-515.33-392.6-200.01
Comprehensive Income & Other
23.6230.3939.0143.2619.3621.71
Total Common Equity
6,9657,1167,2437,2017,5016,369
Minority Interest
96.6473.98102.56223.6412.1612.43
Shareholders' Equity
7,0617,1907,3467,4257,5136,381
Total Liabilities & Equity
9,5949,5278,6048,4549,1747,090

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1,5061,127422.8538.3127.8614.9
Net Cash (Debt)
2,1182,9984,3074,7435,6364,668
Net Cash Growth
-27.01%-30.39%-9.20%-15.83%20.74%12.83%
Net Cash Per Share
3.635.127.358.099.637.93
Filing Date Shares Outstanding
568.11574.86573.72573.52578.69592
Total Common Shares Outstanding
568.11574.86573.72572.21578.69592
Working Capital
3,8404,0685,0355,0305,9545,302
Book Value Per Share
12.2612.3812.6212.5912.9610.76
Tangible Book Value
5,5685,8206,9016,9107,4216,323
Tangible Book Value Per Share
9.8010.1212.0312.0812.8210.68
Buildings
-930.5834.41826.53344.51231.04
Machinery
-830.15607.96436.62322.65270.13
Construction In Progress
-84.833.584.59267.76110.45